Poster Presenters
Joshua J. Kleinman, University of Miami Miller School of Medicine, USA
Title: Metabolomics in predicting radiotherapy-induced normal tissue-toxicities in breast cancer patients
Gavin Ajami, University of Miami School of Medicine, USA
Title: Inflammatory biomarker in radiotherapy-related pain
Saad Alobid, College of Pharmacy, Nova Southeastern University, USA
Title: CDK1 promotes angiogenesis via regulating HIF-1α activity in MDM2 overexpressed prostate cancer
Mohammad Algahtani, College of Pharmacy, Nova Southeastern University, USA
Title: F16 is a novel new candidate for brain tumors
Ali Alaseem, College of Pharmacy, Nova Southeastern University, USA
Title: MDM2 overexpressing cancer cell lines control MMPs activity
Khalid Alhazzani, College of Pharmacy, Nova Southeastern University, USA
Title: Evaluation of antitumor effects of a novel inhibitor of VEGFR-2 in a colorectal xenograft model
Gregory Watson, H. Lee Moffitt Cancer Center, USA
Title: RPS3 fucosylation in melanoma cell biology
E.L. Albuquerque, Universidade Federal do Rio Grande do Norte, Natal-RN, Brazil
Title: Check point inhibitor technique to treat breast cancer
U.L. Fulco, Universidade Federal do Rio Grande do Norte, Natal-RN, Brazil
Title: Quantum biochemistry approach to investigate the binding energy features of a cilengitide RGD-Integrin compound
Keerthi Thallapureddy, Nova Southeastern University, Florida
Title: Evaluation of crosstalk between FAK and MDR1 in platinum resistant ovarian cancer cells
Barzan A Sadiq, Babraham Institute, University of Cambridge, Cambridge, UK
Title: Mouse prostate organoids reveal an essential role for PI3K alpha in mouse prostate cancer growth, metabolism and tumorigenesis and its regulation by the pH level of the tumour microenvironment
Ayca Ece Nezir, Department of Genetics and Bioengineering, Yeditepe University, Turkey
Title: P-12 Targeting of Prostate Cancer with Polymeric Nanocarriers Labelled with PMSABinding Peptide
Gutiérrez-Castañeda Luz D, Biology molecular of virus (Group of Investigation), Faculty of Medicine, Institute of Biotechnology, National University of Colombia. Fundacion Universitaria de Ciencias de la Salud, St. Jose Hospital, Genetics Department Bogota, Colombia
Title: Evaluation of Oncolytic Activity the TRUYO’s Rotavirus in MES-OV Cell Line of Ovarian Cancer
Dilek Telci, Department of Genetics and Bioengineering, Yeditepe University, Turkey
Title: BikDD and Doxorubicin Delivery to AU565 Breast Cancer Cell line by Targeted Lipid Based Nanovesicles